Stimulant Use Disorder Management for Family Medicin... | MDster You are offline Back online! [ ](/) Specialities [ Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ Emergency Medicine ](https://mdster.com/speciality/emergency-medicine) [ Family Medicine ](https://mdster.com/speciality/family-medicine) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ Obstetrics & Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ Pediatrics ](https://mdster.com/speciality/pediatrics) [ Psychiatry ](https://mdster.com/speciality/psychiatry) [ Features ](https://mdster.com/features) [ Pricing ](https://mdster.com/pricing) [ Blog ](https://mdster.com/blog) Menu Specialities [ Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ Emergency Medicine ](https://mdster.com/speciality/emergency-medicine) [ Family Medicine ](https://mdster.com/speciality/family-medicine) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ Obstetrics & Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ Pediatrics ](https://mdster.com/speciality/pediatrics) [ Psychiatry ](https://mdster.com/speciality/psychiatry) [ Features ](https://mdster.com/features) [ Pricing ](https://mdster.com/pricing) [ Blog ](https://mdster.com/blog) [ Login ](https://mdster.com/auth/login) 1. [ Home ](https://mdster.com) 2. [ Blog ](https://mdster.com/blog) 3. [ Medical Education ](https://mdster.com/blog?category=medical-education) 4. Stimulant Use Disorder Supportive Management in Family Medicine [ Medical Education ](https://mdster.com/blog?category=medical-education) Stimulant Use Disorder Supportive Management in Family Medicine ================================================================= A practical, high-yield approach to cardiac counseling, sleep and nutrition support, contingency management, and sorting true ADHD from stimulant-related symptoms. [ MDster Editorial Team ](https://mdster.com/about) · Mar 30, 2026 · 6 min read · 70 [ Reviewed by Dr. Ali Ragab, MBBCH, MSc, MCAI ](https://mdster.com/medical-reviewers/dr-ali-ragab) [Editorial Policy](https://mdster.com/editorial-policy) | [Corrections Policy](https://mdster.com/corrections) [ Family Medicine ](https://mdster.com/blog?tag=family-medicine) [ Addiction Medicine ](https://mdster.com/blog?tag=addiction-medicine) [ Stimulant Use Disorder ](https://mdster.com/blog?tag=stimulant-use-disorder) [ Contingency Management ](https://mdster.com/blog?tag=contingency-management) [ ADHD ](https://mdster.com/blog?tag=adhd) ![Stimulant Use Disorder Supportive Management in Family Medicine](https://mdster.com/storage/blog/images/stimulant-use-disorder-supportive-management-in-family-medicine.jpg) Share this article Share this post In clinic, stimulant use disorder **(StUD)** rarely announces itself as addiction. It shows up as chest tightness, three days without sleep, weight loss, panic, missed visits, or the patient who says methamphetamine is the only thing that lets him focus. In Family Medicine, supportive management is not optional; it is how you prevent MI, stroke, psychosis, dehydration, and dropout while you build engagement. There is still no FDA-approved pharmacologic treatment for StUD, so the backbone of care remains psychosocial treatment plus disciplined supportive follow-up. [\[1\]](#cite-1 "Reference [1]") Start With Risk Framing, Not Moralizing --------------------------------------- Tell patients plainly what stimulants are doing to their body: raising BP and heart rate, suppressing appetite, disrupting sleep, and increasing risk of arrhythmia, ischemia, and even heart failure with ongoing use. Ask specifically about cocaine versus methamphetamine, route, days awake, chest pain, dyspnea, palpitations, syncope, severe headache, and co-use. That history is not paperwork; it separates outpatient management from same-day escalation. [\[2\]](#cite-2 "Reference [2]") Send the patient to the ED now for ongoing chest pain, syncope, focal neurologic symptoms, seizure, hyperthermia, severe agitation, or psychosis. Chest pain in stimulant intoxication still deserves an ACS mindset; do not dismiss it as anxiety. Also remember the current harm-reduction reality: stimulant products may be contaminated with fentanyl, so naloxone counseling is appropriate even when opioids are not the stated drug of choice. [\[2\]](#cite-2 "Reference [2]") > **Clinical Pearl:** The young patient with cocaine use and chest pain does not get a free pass. If the pain is ongoing or not clearly resolving, think ACS until you have proved otherwise. [\[2\]](#cite-2 "Reference [2]") Sleep and Nutrition Are Relapse-Prevention Tools ------------------------------------------------ Do not treat sleep and food as wellness fluff. Dehydration, under-eating, and prolonged wakefulness amplify both physiologic risk and mental distress. Give concrete instructions: hydrate, schedule calories even if appetite is poor, stop stacking caffeine or other stimulants, and protect a dark, low-stimulation sleep window after use. Early withdrawal may bring hypersomnia, followed by persistent insomnia for weeks to months; if you ignore that symptom burden, you invite return to use. [\[3\]](#cite-3 "Reference [3]") Start with behavioral measures, then use symptom-targeted treatment when needed. Be cautious with sedative-hypnotics in patients at high addiction risk. Recheck weight, BP, appetite, and sleep early; those simple metrics tell you whether the patient is actually stabilizing. [\[2\]](#cite-2 "Reference [2]") Know Contingency Management Even If You Do Not Run It ----------------------------------------------------- **Contingency management (CM)** uses tangible rewards for target behaviors such as attendance or stimulant-negative testing, and it remains the **current standard of care** for StUD. CM works best when paired with other behavioral treatments such as CBT or community reinforcement. The board pitfall is assuming there must be a better medication answer; at present, there usually is not. [\[2\]](#cite-2 "Reference [2]") Practically, ask every referral source directly: do you offer CM? If not, what is your evidence-based alternative? That question matters even more now because SAMHSA’s January 2025 advisory explicitly allowed certain federal grant funds to support evidence-based CM under guardrails, although real-world availability is still limited. [\[4\]](#cite-4 "Reference [4]") Do Not Confuse ADHD With Stimulant Chaos ---------------------------------------- The other major pitfall is sloppy ADHD diagnosis. Stimulant intoxication and stimulant withdrawal both mimic ADHD: distractibility, restlessness, irritability, poor executive function, and sleep disruption. ASAM advises clinicians to distinguish short-term withdrawal symptoms from underlying psychiatric disorders, and SAMHSA notes that the **ASRS** is a screener, not a diagnosis; it does not establish childhood onset and, in SUD treatment settings, it is better at ruling ADHD out than ruling it in. [\[2\]](#cite-2 "Reference [2]") QuestionFavors primary ADHDFavors stimulant effect or withdrawalTime courseLongstanding pattern predating heavy useSymptoms track binges, crashes, or early abstinenceSleepBaseline inattention with some routine sleepMinimal sleep during use, then hypersomnia or persistent insomniaAssessmentMulti-visit history; screener is only a first stepReassess after stabilization; do not diagnose from one chaotic visit That table is the bedside distinction boards love. If ADHD looks real, do not ignore it: ASAM recommends treating ADHD as part of StUD care. When benefits outweigh risks, extended-release stimulants may be used with closer monitoring; when risks dominate, use non-stimulants and behavioral treatment. If you do prescribe a stimulant in a patient with StUD, prefer extended-release formulations and monitor with PDMP checks, pill counts, toxicology, and more frequent follow-up, especially when hypertension, cardiovascular disease, or psychosis is present. [\[2\]](#cite-2 "Reference [2]") Clinical Correlations --------------------- In Family Medicine, supportive care works best when it is scheduled and specific: frequent early follow-up, vitals and weight at each visit, direct questions about last use and last sleep, suicide screening during withdrawal, dental and skin review, referral to a program that can deliver CM or CBT, and naloxone counseling. Supportive management is not a placeholder while you wait for specialty care; for many patients, it is the treatment that keeps them alive and engaged long enough to recover. [\[2\]](#cite-2 "Reference [2]") Key Takeaways ------------- - **No FDA-approved medication** currently treats StUD; psychosocial treatment remains the foundation. [\[1\]](#cite-1 "Reference [1]") - **Contingency management** is the evidence-based standard of care; know who offers it locally. [\[2\]](#cite-2 "Reference [2]") - **Cardiac counseling matters**: unresolved chest pain, syncope, stroke symptoms, seizure, hyperthermia, or severe agitation means emergency evaluation. [\[2\]](#cite-2 "Reference [2]") - **Sleep, food, and hydration are relapse-prevention tools**, not soft add-ons. [\[3\]](#cite-3 "Reference [3]") - **Do not diagnose ADHD from one screener or one unstable visit**; if true ADHD is present, treat it concurrently and monitor closely. [\[2\]](#cite-2 "Reference [2]") Conclusion ---------- Supportive management of StUD is disciplined outpatient medicine: risk-stratify the heart and brain, restore sleep and calories, connect patients to CM, and refuse to confuse stimulant-related chaos with primary ADHD. Do that well, and you are practicing real addiction medicine in Family Medicine. [\[2\]](#cite-2 "Reference [2]") References (5) ------------------ 1. 1. [ FDA Prescription Stimulant Medications: Evidence-Based Treatments for Stimulant Use Disorders ](https://www.fda.gov/drugs/information-drug-class/prescription-stimulant-medications) [↩](#cite-ref-1-1 "Back to text") 2. 2. [ ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder ](https://www.aaap.org/wp-content/uploads/2023/11/stud_guideline_document_final.pdf) [↩](#cite-ref-2-1 "Back to text") 3. 3. [ CDC Stimulant Guide: Information and Harm Reduction for People Who Use Stimulants ](https://www.cdc.gov/overdose-prevention/media/pdfs/2024/03/CDC-Stimulant-Guide.pdf) [↩](#cite-ref-3-1 "Back to text") 4. 4. [ SAMHSA Advisory: Using SAMHSA Funds to Implement Evidence-Based Contingency Management Services (January 2025) ](https://library.samhsa.gov/product/using-samhsa-funds-implement-evidence-based-contingency-management-services/pep24-06-001) [↩](#cite-ref-4-1 "Back to text") 5. 5. [ SAMHSA Advisory: Adults With Attention Deficit Hyperactivity Disorder and Substance Use Disorders ](https://library.samhsa.gov/product/advisory-adults-attention-deficit-hyperactivity-disorder-and-substance-use-disorders/sma15) Keep going Stay consistent in Family Medicine prep with a guided pathway --------------------------------------------------------------- - Broad coverage without the overwhelm - Short daily sessions that compound - See your progress and focus on weak areas [ Start practicing ](https://mdster.com/user/dashboard) [ Explore Family Medicine ](https://mdster.com/speciality/family-medicine) [ View pricing ](https://mdster.com/pricing) [ Explore features ](https://mdster.com/features) No credit card required. Full access to all features. No commitment. Cancel anytime. [ Back to all posts ](https://mdster.com/blog) Discussion () ----------------- Join the discussion [ Log in ](https://mdster.com/auth/login) or [ Sign up ](https://mdster.com/auth/register) No comments yet Be the first to share your thoughts! ![]() Related Posts ------------- [ ![Anxiety, Depression, and Breathlessness in Severe COPD/Asthma Overlap](https://mdster.com/storage/blog/images/anxiety-depression-and-breathlessness-in-severe-copdasthma-overlap.jpg) Medical Education ### Anxiety, Depression, and Breathlessness in Severe COPD/Asthma Overlap A focused Family Medicine review of anxiety, depression, and dyspnea in severe COPD/asthma overlap, with safer prescribing, breathing retraining, and board-style pitfalls. 6 min read 0 comments ](https://mdster.com/blog/anxiety-depression-and-breathlessness-in-severe-copdasthma-overlap) [ ![IBS Subtypes and Diagnosis: Rome IV, IBS-C/D, and Colonoscopy](https://mdster.com/storage/blog/images/ibs-subtypes-and-diagnosis-rome-iv-ibs-cd-and-colonoscopy.jpg) Medical Education ### IBS Subtypes and Diagnosis: Rome IV, IBS-C/D, and Colonoscopy A focused Internal Medicine review of IBS diagnosis: how to use Rome IV concepts, separate IBS-C from IBS-D and mixed IBS, and decide when colonoscopy is truly indicated. 7 min read 0 comments ](https://mdster.com/blog/ibs-subtypes-and-diagnosis-rome-iv-ibs-cd-and-colonoscopy) [ ![Congenital Hypothyroidism: Screening, Levothyroxine, Outcomes](https://mdster.com/storage/blog/images/congenital-hypothyroidism-screening-levothyroxine-outcomes.jpg) Medical Education ### Congenital Hypothyroidism: Screening, Levothyroxine, Outcomes High-yield review of congenital hypothyroidism for Pediatrics trainees, covering newborn screening pitfalls, urgent levothyroxine treatment, and developmental follow-up. 6 min read 0 comments ](https://mdster.com/blog/congenital-hypothyroidism-screening-levothyroxine-outcomes) [ ](/) Master your medical exams with evidence-based learning. [ GET IT ON Google Play ](https://play.google.com/store/apps/details?id=com.mdster.app) ### Platform - [Home](https://mdster.com) - [Features](https://mdster.com/features) - [Pricing](https://mdster.com/pricing) - [About](https://mdster.com/about) ### Resources - [Blog](https://mdster.com/blog) - [Dashboard](https://mdster.com/user/dashboard) ### Support - [Contact](https://mdster.com/contact) - [Legal & Policies](https://mdster.com/legal) - [Medical Reviewers](https://mdster.com/medical-reviewers) © 2026 MDster [ ](https://play.google.com/store/apps/details?id=com.mdster.app) [Terms](https://mdster.com/terms) [Privacy](https://mdster.com/privacy) [Editorial](https://mdster.com/editorial-policy) reCAPTCHA Protected by reCAPTCHA. Google [Privacy Policy](https://policies.google.com/privacy) and [Terms of Service](https://policies.google.com/terms) apply. Cookie Consent -------------- We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. [ Terms of Use ](https://mdster.com/terms) & [ Privacy Policy ](https://mdster.com/privacy) Accept